View in EDS

412PDClinical activity, safety, and PK/PD from a phase I study of RO6874281, a fibroblast activation protein (FAP) targeted interleukin-2 variant (IL-2v).

Saved in:
Bibliographic Details
Title: 412PDClinical activity, safety, and PK/PD from a phase I study of RO6874281, a fibroblast activation protein (FAP) targeted interleukin-2 variant (IL-2v).
Authors: Melero, I1 (AUTHOR), Alvarez, E Castanon2 (AUTHOR), Mau-Sorensen, M3 (AUTHOR), Lassen, U N4 (AUTHOR), Lolkema, M P5 (AUTHOR), Robbrecht, D G6 (AUTHOR), Gomez-Roca, C A7 (AUTHOR), Martin-Liberal, J8 (AUTHOR), Tabernero, J9 (AUTHOR), Ros, W10 (AUTHOR)
Source: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdy279.400